IPO registrations (S-1, F-1) · Registrants
Viskase Holdings, Inc.
- SEC CIK
- 727510 · filings on EDGAR ↗
- Name on the registration
- ENZON PHARMACEUTICALS, INC.
- Former names
- ENZON PHARMACEUTICALS, INC. (2016–2026); ENZON PHARMACEUTICALS INC (2006–2016); ENZON PHARMACEUTICALS INC (2002–2006); ENZON PHARMACEUTICAL INC (2002–2002); ENZON INC (1995–2002)
- Registration
- Form S-1, first filed 2020-09-01, last 2020-11-12; 2 initial registrations, 1 amendment
- Outcome
- Declared effective 2020-09-21
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, Lombard, IL 60148
- EIN
- 22-2372868
- Ticker
- VISK (OTC)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Viskase Holdings, Inc. on the corporate pages
Offering terms
- Shares offered
- 36,056,636
- Listing
- OTCQX under the symbol ENZN
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: ENZON PHARMACEUTICALS, INC. EXACT (EIN (EXACT))
- SEC filer: ENZON PHARMACEUTICALS INC EXACT (CIK (EXACT))
- Person page: Andrew D Rackear Esq Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
- Person page: Stephen T Wills Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 5
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-09-01 | S-1 | S-1 (registration) | ENZON PHARMACEUTICALS, INC. | 0001104659-20-101387 ↗ |
| 2020-09-15 | S-1/A | S-1/A (amendment) | ENZON PHARMACEUTICALS, INC. | 0001104659-20-105076 ↗ |
| 2020-09-21 | EFFECT | EFFECT (declared effective) | ENZON PHARMACEUTICALS, INC. | 9999999995-20-002518 ↗ |
| 2020-11-12 | S-1 | S-1 (registration) | ENZON PHARMACEUTICALS, INC. | 0001104659-20-124408 ↗ |
| 2020-11-23 | EFFECT | EFFECT (declared effective) | ENZON PHARMACEUTICALS, INC. | 9999999995-20-003279 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-11-12 | S-1 | registration statement | $0.01 | 36,056,636 | $360,566 | OTCQX ENZN | 0 | primary document; price sentence, shares headline, proceeds computed | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ANDO GORAN | Director | 9 | 2006–2009 | ||
| CLASSON ROLF A | Director | 13 | 2006–2011 | ||
| DIXON ROSINA B | Director | 1 | 2006 | ||
| LEBUHN ROBERT | Director | 21 | 2006–2013 | ||
| MICATI VICTOR P | Director | 11 | 2006–2010 | ||
| Renfro Phillip M | Director | 10 | 2006–2009 | ||
| SALISBURY ROBERT C | Director | 17 | 2006–2013 | ||
| BUCHALTER JEFFREY H | Director,Officer | CEO & President; Chairman, CEO & President; Chairman of the Board & CEO | 13 | 2006–2010 | |
| HORAK IVAN D | Officer | EVP, President of R&D and CSO; EVP-R&D & Chief Scien. Officer; EVP, R&D, Chief Scientific Ofc; EVP, R&D, Chief Scientific Off; EVP, R&D, Chief Sci Officer; EVP, R&D, Chief Sci. Officer; EVP, R&D & Ch. Scientific Off.; EVP, R&D, CSO; EVP,R&D, CSO; President of R&D | 22 | 2006–2011 | |
| TOOMAN CRAIG A | Officer | EVP, Finance & CFO; EVP, FINANCE, CFO; Exec VP Finance, CFO; Exec. V.P. Finance, CFO; Exec. VP Finance, CFO | 19 | 2006–2010 | |
| Davit Paul Stephen | Officer | EVP, Human Resources; Exec. Vice Pres. HR | 20 | 2006–2011 | |
| del Campo Ralph | Officer | Chief Operating Officer; COO and Princ. Exec. Officer; COO and Principal Exec Officer; EVP - Technical Operations; EVP, Technical Operations; EVP-Technical Operations | 21 | 2006–2011 | |
| Dubin Glenn | TenPercentOwner | 11 | 2007–2008 | ||
| HIGHBRIDGE CAPITAL CORP | TenPercentOwner | 3 | 2007 | ||
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | TenPercentOwner | 11 | 2007–2008 | ||
| Highbridge Convertible Arbitrage Master Fund, L.P. | TenPercentOwner | 8 | 2007–2008 | ||
| Highbridge International LLC | TenPercentOwner | 11 | 2007–2008 | ||
| Swieca Henry | TenPercentOwner | 11 | 2007–2008 | ||
| Geltosky John | Director | 4 | 2008–2009 | ||
| Denner Alexander J | Director | 9 | 2009–2013 | ||
| Mulligan Richard | Director | 9 | 2009–2013 | ||
| IRIDIAN ASSET MANAGEMENT LLC/CT | TenPercentOwner | 1 | 2009 | ||
| Levy Harold J | Director | 2 | 2009–2010 | ||
| Deuel Thomas | Director | 8 | 2010–2013 | ||
| Young Richard A | Director | 9 | 2010–2013 | ||
| Ogden Mark L | Officer | Acting VP of Fin & Prin FO; VP of Finance & PFO | 2 | 2010–2011 | |
| ICAHN CARL C | TenPercentOwner | 6 | 2011–2026 | ||
| Stancic Ana | Officer | Executive VP, COO, PEO CFO; Executive VP, COO, PEO, CFO; Senior VP, Finance and CFO | 5 | 2011–2012 | |
| Buchbinder Aby | Officer | VP, Clinical Development | 6 | 2011–2013 | |
| Greenberger Lee M | Officer | VP, Research | 3 | 2011–2012 | |
| Rackear Andrew D. | Officer | CEO and Secretary; VP and General Counsel | 8 | 2011–2016 | person page Fuzzy |
| Daly Timothy | Officer | VP, Controller and PAO | 3 | 2011–2012 | |
| Conover Charles | Officer | SVP, R&D Program Management | 4 | 2012–2013 | |
| HEBARD GEORGE | Director; Director,Officer | Interim PEO and Interim COO | 4 | 2012 | |
| Kostas Odysseas D | Director | 1 | 2013 | ||
| McNealey Jennifer Isacoff | Director | 1 | 2013 | ||
| CHRISTODORO JONATHAN | Director | 1 | 2013 | ||
| FEINSTEIN RICHARD L | Officer | VP-Finance and PFO | 1 | 2013 | |
| Couchman Family Fund | Other; TenPercentOwner; TenPercentOwnerOther | 10 | 2018–2021 | ||
| COUCHMAN JONATHAN | TenPercentOwner; TenPercentOwnerOther | 10 | 2018–2021 | ||
| Xstelos Corp. | Other; TenPercentOwner; TenPercentOwnerOther | 10 | 2018–2021 | ||
| Myrexis, Inc. | Other; TenPercentOwner | 6 | 2020–2021 | ||
| HARPER ASSET MANAGEMENT LLC | Other | 3 | 2020 | ||
| Harper Brian James | Other | 3 | 2020 | ||
| Pearce Michael Cooper | Other | 3 | 2020 | ||
| READ RANDOLPH C | Director | 3 | 2020–2023 | ||
| Bleznick Jordan | Director | 2 | 2020 | ||
| Firestone Jaffrey Adam | Director | 1 | 2022 | ||
| WILLS STEPHEN T | Director | 1 | 2025 | person page Fuzzy | |
| Blecic Michael | Officer | See Remarks | 1 | 2026 | |
| Davis Thomas Dale | Officer | See Remarks | 1 | 2026 | |
| DeMaria Dustin | Director | 1 | 2026 | ||
| Flint Robert | Director | 1 | 2026 | ||
| Herrera Armando Jr. | Officer | See Remarks | 1 | 2026 | |
| King Joseph D | Officer | See Remarks | 1 | 2026 | |
| Kwak Colin Nicholas | Director | 1 | 2026 | ||
| Plescia John | Officer | See Remarks | 1 | 2026 | |
| Schouten Robert | Officer | See Remarks | 1 | 2026 | |
| Shea Kenneth | Director | 1 | 2026 | ||
| SHEA PETER | Director | 1 | 2026 | ||
| Stender Mackenzie | Officer | See Remarks | 1 | 2026 | |
| Stevens Jan | Officer | See Remarks | 1 | 2026 | |
| ICAHN ENTERPRISES G.P. INC. | TenPercentOwner | 1 | 2026 | ||
| ICAHN ENTERPRISES HOLDINGS L.P. | TenPercentOwner | 1 | 2026 | ||
| Pettit Craig | Director | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | Viskase Holdings, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | ENZON PHARMACEUTICALS, INC. | EIN (EXACT) | ||
| Person page | Andrew D Rackear Esq | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) | |
| Person page | Stephen T Wills | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), IL first:
- AveXis, Inc. IL
- BioLife4D Corp IL
- APPLIED NEUROSOLUTIONS INC IL
- NEOPHARM INC IL
- BioNTech SE 2M
- Immatics N.V. 2M
- CHEMOKINE THERAPEUTICS CORP A1
- Fusion Pharmaceuticals Inc. A6
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. AZ
- GENETIC TECHNOLOGIES LTD C3
In other datasets, the same topic (Health) in IL:
- Nonprofit: 5 LOAVES 2 FISHES FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health